510(k) · Cleared
ClearedHyPHo Laser System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Hyper Photonics Srl · GEX Powered Laser Surgical Instrument
Cleared on Jun 23, 2017 as substantially equivalent to K140388 (Lumenis, Ltd., 2014) and 1 other predicate after a 197-day review. Its family tree reaches back 7 generations to 1994.
- Decided
- Jun 23, 2017
- Review
- 197 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 7 generations to K936109 (1994). 34 ancestors in all, the oldest K853620 (1986). No later device cites it as a predicate yet.
- Root · 7 generations backK936109 Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc. · 1994
- 6 generations backK960521 Sharplan Lasers, Inc. Silktouch Flash ScannerSharplan Lasers, Inc. · 1996
- 5 generations backK963339 Coherent Ultrapulse CO2 Surgical LasersCoherent Medical Group · 1997
- 4 generations backK974789 Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and LLumenis, Inc. · 1998
- 3 generations backK990947 Modified Versapulse Select Single Wavelength, HO: Yag and Dual…Lumenis, Inc. · 1999
- 2 generations backK011703 Lumenis Versapulse Powersuite Holmium (HO:Yag) and Dual Wavelength…Lumenis · 2001 · Recalled
- 1 generation backK140388 Lumenis Pulse 120HLumenis, Ltd. · 2014
- This deviceK163449 HyPHo Laser SystemHyper Photonics Srl · 2017
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −7 | K936109 | Sharplan Model 1120 CO2 Surgical Laser | Sharplan Lasers, Inc. | 1994 | — |
| −6 | K960521 | Sharplan Lasers, Inc. Silktouch Flash Scanner | Sharplan Lasers, Inc. | 1996 | — |
| −5 | K963339 | Coherent Ultrapulse CO2 Surgical Lasers | Coherent Medical Group | 1997 | — |
| −4 | K974789 | Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and L | Lumenis, Inc. | 1998 | — |
| −3 | K990947 | Modified Versapulse Select Single Wavelength, HO: Yag and Dual Wavelength, HO… | Lumenis, Inc. | 1999 | — |
| −2 | K011703 | Lumenis Versapulse Powersuite Holmium (HO:Yag) and Dual Wavelength… | Lumenis | 2001 | 2 |
| −1 | K140388 | Lumenis Pulse 120H | Lumenis, Ltd. | 2014 | — |
| 0 (this device) | K163449 | HyPHo Laser System | Hyper Photonics Srl | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2004 | 1 | 0 |
| 2009 | 1 | 0 |
| 2014 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K140388 | Lumenis Pulse 120HSummary page 7…urgery Predicate Devices: - Modified Lumenis VersaPulse PowerSuite Holmiumn (Ho:YAG) Surgical Lasers and - Delivery Devices and Accessories - Lumenis Pulse 120H (K140388); - Modified Quanta System LITHO Laser System (K141101). Intended use/ Indications for Use:… | 2014 |
| * | K141101 | LITHOSummary page 7…e PowerSuite Holmiumn (Ho:YAG) Surgical Lasers and - Delivery Devices and Accessories - Lumenis Pulse 120H (K140388); - Modified Quanta System LITHO Laser System (K141101). Intended use/ Indications for Use: 23 The Hyper Photonics’s HY… | 2014 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 1.9 years on median.
- 1 of the 34 ancestors has a recall of any class.
- 5 other devices also cite its predicate K140388.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The Hyper Photonics’s HYPHO (Ho:YAG) Surgical Laser and Delivery Devices and Accessories (Hyper Photonics optical fibers) is intended for use in surgical procedures involving open, laparoscopic and endoscopic ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: urology; urinary lithotripsy; arthroscopy; discectomy; E.N.T. surgery; gynecological surgery; pulmonary surgery; gastroenterology surgery…
Read the full statement (575 words)
The Hyper Photonics’s HYPHO (Ho:YAG) Surgical Laser and Delivery Devices and Accessories (Hyper Photonics optical fibers) is intended for use in surgical procedures involving open, laparoscopic and endoscopic ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: urology; urinary lithotripsy; arthroscopy; discectomy; E.N.T. surgery; gynecological surgery; pulmonary surgery; gastroenterology surgery; dermatology and plastic surgery and general surgery. The HYPHO Laser System and its delivery system (Hyper Photonics optical fibers) are indicated for use in the performance of specific surgical applications as follows:
Urology
- Endoscopic transurethral incision of the prostate (TUIP), bladder neck incision of the prostate (BNI), holmium laser ablation of the prostate (HoLAP), holmium laser resection of the prostate (HoLRP), hemostasis, vaporization and excision for treatment of benign prostatic hypertrophy (BPH)
- Open and endoscopic urological surgery (ablation, vaporization, incision, excision and coagulation of soft tissue) including treatment of:
▪ bladder;
▪ superficial and invasive bladder, urethral and ureteral tumors;
▪ condylomas;
▪ lesions of external genitalia;
▪ ureteral and penile hemangioma;
▪ ureteral strictures;
▪ bladder neck obstructions
Urinary Lithotripsy including:
o endoscopic fragmentation of urinary (urethral, ureteral, bladder and renal) calculi, including cystine, calcium oxalate, monohydrate and calcium oxalate dihydrate stones;
o treatment of distal impacted fragments of steinstrasse when guide wires cannot be passed.
Arthroscopy
o Arthroscopy (ablation, excision and coagulation of soft and cartilaginous tissue) in various small and large joints of the body, excluding the spine, including:
meniscectomy;
plica removal;
ligament and tendon release;
contouring and sculpting of articular surfaces;
debridement of inflamed synovial tissue (synovectomy);
loose body debridement;
chondromalacia and tears;
lateral retinecular release;
capsulectomy in the knee;
chondroplasty in the knee;
chondrornalacia ablation.
o Discectomy including:
percutaneous vaporization of the L4-5 and L5-SI lumbar discs of the vertebral spine; open and arthroscopic spine procedures;
foraminotomy.
General Surgery
o Open, laparoscopic, and endoscopic general surgery (vaporization, ablation, incision, and coagulation of soft tissue) including:
cholecystectomy;
lysis of adhesions;
appendectomy;
biopsy. pylorostenotomy, and removal of polyps of the sigmoid colon;
skin incision;
tissue dissection;
excision of external tumors and lesions;
complete or partial resection of internal organs, tumors and lesions;
mastectomy;
hepatectomy;
pancreatectomy;
splenectomy;
thyroidectomy;
parathyroidectomy;
hemniorrhaphy;
tonsillectomy;
lymphadenectomy;
partial nephrectomy;
pilonidal cystectomy;
resection of lipoma;
debridement of decubitus ulcer;
hemorrhoids;
debridenment of statis ulcer;
biopsy.
ENT Surgery
o Endoscopic endonasal/ sinus surgery (ablation, vaporization, incision, and coagulation of soft tissue and cartilage) including:
partial turbinectomy;
ethmoidectorny;
polypectomy;
maxillary antrostomy;
frontal sinusotomy;
sphenoidotomy;
dacryocystorhinostomy (DCR);
functional endoscopic sinus surgery (FESS).
Gynecological Surgery
o Open and laparoscopic gynecological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue).
Gastroenterology Surgery
o Open and endoscopic gastroenterology surgery (ablation, vaporization, incision, excision, resection, coagulation and hemostasis, including:
gall bladder calculi;
biliary /bile duct calculi;
benign and malignant neoplasm;
polyps;
colitis;
ulcers;
angiodysplasia;
hemorrhoids;
varices;
esophagitis;
esophageal ulcer;
Mallory-Weiss tear;
gastric ulcer;
duodenal ulcer;
non-bleeding ulcer;
gastric erosions:
colorectal cancer;
gastritis;
bleeding tumnors;
pancreatitis;
vascular malformations:
telangiectasis;
telangiectasias of the Osler-Weber-Renu disease.
Pulmonary Surgery
o Open and endoscopic pulmonary surgery (cutting, ablation, vaporization, incision, excision and coagulation of soft tissue.
Dermatology and plastic surgery
Incision, excision, resection, ablation, coagulation, hemostasis and vaporization of soft, mucosal, fatty and cartilaginous tissues, in therapeutic plastic, dermatologic and aesthetic surgical procedures.
including:
scars;
tattoo removal;
vascular lesions:
port wine stains;
hemangioma;
telangiectasia of the face and leg;
rosacea;
corns;
papillomas:
basal cell carcinomas;
lesions of skin and subcutaneous tissue;
plantar warts;
periungual and subungual warts;
debridement of decubitus ulcer;
skin tag vaporization.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K163449 · printed Nov 6, 2026
Cite this page
510(k) Report. “K163449: HyPHo Laser System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K163449
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026